Long time readers have been aware that, for some time, Equity.Guru has been a supporter of Canntab Therapeutics (PILL.C), but have been frustrated watching the company being slow on…
Today’s Analysis
In this episode, we revisit Valeo Pharma (VPH.C) to get an update on their product portfolio, stock price, and financials. Is VPH.C a good long term investment? Tune In!…
Valeo Pharma (VPH.C) is a specialty pharmaceutical company, engages in the acquisition, in-licensing, and commercialization of pharmaceutical products with a primary focus on neurodegenerative diseases, oncology and supportive care, and…
Welcome to Equity.Guru’s Roundtable where our writers weigh in on the pros and cons of a spotlight company, break out where they see value, and help you avoid public…
Valeo Pharma (VPH.C) is a specialty pharmaceutical company that sources, acquires, or in-licenses brand and generic products for sale in Canada. Valeo’s business objective is to become an anchor…
Jody catches up with the CEO of Valeo Pharma (VPH.C), Steve Saviuk, to talk more about their specialty product. Redesca, and Asthma products, Enerzair® breezhaler® and Atectura® breezhaler®. Based…
SKRR Exploration Inc. (SKRR.V) is a junior mining company that operates as a precious metal explorer with its head office in Vancouver BC. It explores gold deposits and holds…
SKRR Exploration (SKRR.V) is a junior Gold explorer which owns three properties in the under explored Trans Hudson Corridor in Saskatchewan. This area can potentially be Canada’s next emerging Gold district…
Welcome to Equity.Guru’s Roundtable where our writers weigh in on the pros and cons of a spotlight company, break out where they see value, and help you avoid public…
Welcome to Equity.Guru’s Roundtable where our writers weigh in on the pros and cons of a spotlight company, break out where they see value, and help you avoid public…